Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Yoshihiko Hatanaka
Age : 64
Country of residence : Unknown
Linked companies : Sony Group Corporation - Astellas Pharma Inc.

Biography of Yoshihiko Hatanaka 
Currently, Yoshihiko Hatanaka is Chairman of Astellas Pharma, Inc. He is also on the board of Sony Corp. In his past career he occupied the position of Chairman & Chief Executive Officer of Astellas Pharma US, Inc., President & Chief Executive Officer at Astellas US LLC and Director-Corporate Planning at Fujisawa Pharmaceutical Co., Ltd. He received an undergraduate degree from the University of Hitotsubashi.


Current positions of Yoshihiko Hatanaka 
Yoshihiko Hatanaka : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/07JEFF BEZOS : Amazon's billionaire founder Jeff Bezos to fly to space next month
RE
06/04JACK DORSEY : Square considering making bitcoin hardware wallet -Dorsey
RE
06/02BILL GATES : Bill Gates' next generation nuclear reactor to be built in Wyoming
RE
06/08CHAMATH PALIHAPITIYA : Palihapitiya's $16 million bet on Clover worth $682 million on Reddit rally
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/04WILLIAM ACKMAN : Ackman reinvents SPAC in Universal Music deal talks
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
06/10MARIA MARTINEZ : French Industrial Production Unexpectedly Declined in April
DJ
More news


© 2021 People and Ownership :   
Yoshihiko Hatanaka : Connections 


Latest news about Yoshihiko Hatanaka 
2018Astellas Pharma Inc. Announces Board Changes; Effective Date from April 1, 2018
CI
2017Astellas Pharma Mulls Acquisitions
CI
2016Astellas Pharma Seeks Acquisitions
CI
2012Investors likely to wait out 2012 drug launches
RE
More news